生血宝合剂联合多糖铁复合物胶囊治疗妊娠合并地中海贫血的疗效及对妊娠结局的影响
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R714.254

基金项目:

嘉兴市科技计划项目(2022AD30094)


Efficacy of Shengxuebao Mixture Combined with Iron Polysaccharide Complex Capsules in the Treatment of Gestational Mediterranean Anemia and Its Effect on Pregnancy Outcomes
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察生血宝合剂联合多糖铁复合物胶囊对妊娠合并地中海贫血的疗效及对妊娠结局的影响。 方法:选取2022年2月—2024年5月于嘉兴市妇幼保健院确诊为地中海贫血的100例孕妇为研究对象,按随机 数字表法分为对照组及治疗组各50例。对照组给予多糖铁复合物胶囊治疗,治疗组给予生血宝合剂联合多糖 铁复合物胶囊治疗。2组均治疗4周。比较2组临床疗效、不良反应发生率及妊娠结局,比较2组治疗前后的平 均红细胞体积(MCV)、平均红细胞血红蛋白含量(MCH)、血红蛋白(Hb)、血清铁蛋白(SF) 及中医证候评 分。结果:治疗组临床疗效总有效率为94.00%(47/50),对照组为78.00%(39/50),2组比较,差异有统计学 意义(P<0.05)。治疗后,2组MCV、MCH、Hb、SF水平均较治疗前上升(P<0.05),治疗组MCV、MCH、 Hb、SF 水平均高于对照组(P<0.05)。治疗后,2 组面色萎黄、潮热盗汗、心悸气短评分均较治疗前下 降(P<0.05),治疗组上述3项中医证候评分均低于对照组(P<0.05)。治疗期间,对照组不良反应发生率为 6.00%(3/50),治疗组为8.00%(4/50),2组比较,差异无统计学意义(P>0.05)。对照组不良妊娠结局发生 率为28.00%(14/50),治疗组为12.00%(6/50),2组比较,差异有统计学意义(P<0.05)。结论:生血宝合剂 联合多糖铁复合物胶囊能改善妊娠合并地中海贫血患者缺铁贫血的症状,提升造血功能,有效降低不良妊娠结 局发生率,安全性高。

    Abstract:

    Abstract: Objective: To observe the efficacy of Shengxuebao Mixture combined with Iron Polysaccharide Complex Capsules in the treatment of gestational Mediterranean anemia and its effect on pregnancy outcomes. Methods: A total of 100 pregnant women diagnosed with Mediterranean anemia at Jiaxing Maternity and Child Health Care Hospital from February 2022 to May 2024 were enrolled. They were divided into the control group and the treatment group according to the random number table method,with 50 cases in each group. The control group was treated with Iron Polysaccharide Complex Capsules, while the treatment group received Shengxuebao Mixture combined with Iron Polysaccharide Complex Capsules. Both groups were treated for four weeks. The clinical efficacy,incidence of adverse reactions, and pregnancy outcomes were compared between the two groups. Changes in mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), hemoglobin (Hb), serum ferritin (SF), and traditional Chinese medicine syndrome scores before and after treatment were also compared. Results:The total clinical effective rate was 94.00% (47/50) in the treatment group and 78.00% (39/50) in the control group, showing a statistically significant difference between the two groups (P<0.05). After treatment, the levels of MCV, MCH, Hb, and SF increased in both groups compared to before treatment (P<0.05),and the levels of these indicators in the treatment group were higher than those in the control group (P<0.05). After treatment,the scores of sallow complexion,tidal fever and night sweats, and palpitation and shortness of breath decreased in both groups compared to before treatment (P<0.05),and these three traditional Chinese medicine syndrome scores in the treatment group were lower than those in the control group (P<0.05). During treatment,the incidence of adverse reactions was 6.00% (3/50) in the control group and 8.00% (4/50) in the treatment group,with no statistically significant difference between the two groups (P>0.05). The incidence of adverse pregnancy outcomes was 28.00% (14/50) in the control group and 12.00% (6/50) in the treatment group,showing a statistically significant difference between the two groups (P<0.05). Conclusion: Shengxuebao Mixture combined with Iron Polysaccharide Complex Capsules can improve symptoms of iron deficiency anemia, enhance hematopoietic function, effectively reduce the incidence of adverse pregnancy outcomes,and exhibits high safety in patients with gestational Mediterranean anemia.

    参考文献
    相似文献
    引证文献
引用本文

杨玉秋,张玥,胡国强.生血宝合剂联合多糖铁复合物胶囊治疗妊娠合并地中海贫血的疗效及对妊娠结局的影响[J].新中医,2026,58(7):28-32

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-04-20
  • 出版日期:
文章二维码